Results
eNauka >
Results >
A randomized phase II study investigating cilengitide added to standard chemoradiotherapy in patients with newly diagnosed glioblastoma with unmethylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Initial report of the CORE study
| Title: | A randomized phase II study investigating cilengitide added to standard chemoradiotherapy in patients with newly diagnosed glioblastoma with unmethylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Initial report of the CORE study | Authors: | Nabors, Louis Burt; Fink, Karen L; Mikkelsen, Tom; Grujicic, Danica M; Tarnawski, Rafal; Nam, Do-Hyun; Perry, James R; Mazurkiewicz, Maria; Picard, Martin; Reardon, David A | Issue Date: | 2013 | Publication: | EUROPEAN JOURNAL OF CANCER | ISSN: | 0959-8049 European Journal of Cancer / EJC Search Idenfier |
Type: | Conference Paper | Collation: | vol. 49 str. S17-S18 | WoS-ID: | 000209470600045 | URI: | https://enauka.gov.rs/handle/123456789/831250 | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
2
WEB OF SCIENCETM
Google ScholarTM
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.